Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma

Hepatology International

Volumn 8, Issue 4, 2014, Pages 567-575

  Sun, Ying ^a   Xi, Dong ^a   Ding, Wen ^a   Wang, Faxi ^a   Zhou, Haili ^a   Ning, Qin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

HCC; Hepatic stellate cells; Immune regulation; LX2 cells; Soluble FGL2 protein; T cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBRINOGEN; GAMMA INTERFERON; PROTEIN ANTIBODY; SOLUBLE FGL2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; STELLATE CELL; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 84919860979     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-014-9568-y     Document Type: Article

References (39)

1. Thun MJ, et al. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100–110
2. Unitt E, et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005;41(4):722–730
3. Winau F, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity. 2007;26(1):117–129
4. Chen CH, et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 2006;44(5):1171–1181
5. Xia YH, et al. T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma. Oncol Rep 2013;30(3):1175–1184
6. Amann T, et al. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 2009;100(4):646–653
7. Mikula M, et al. Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J Cell Physiol 2006;209(2):560–567
8. Zhao W, et al. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma. Int J Oncol 2012;41(2):457–464
9. Zhao W, et al. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer 2011;129(11):2651–2661
10. Doolittle RF. The structure and evolution of vertebrate fibrinogen: a comparison of the lamprey and mammalian proteins. Adv Exp Med Biol 1990;281:25–37
11. Levy GA, et al. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol 2000;156(4):1217–1225
12. Marsden PA, et al. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003;112(1):58–66
13. Chan CW, et al. Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol 2002;168(10):5170–5177
14. Ding Y, et al. Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes. J Huazhong Univ Sci Technol Med Sci 2010;30(5):575–581
15. Melnyk MC, et al. The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis. Scand J Rheumatol 2011;40(4):269–278
16. Chen T, et al. Fgl2 prothrombinase is involved in severe acute pancreatitis-associated liver injury. Hepatogastroenterology. 2012;59(116):1225–1229
17. Liu Y, et al. Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int 2012;32(10):1585–1595
18. Selzner N, et al. FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol 2012;56(1):153–159
19. Marazzi S, et al. Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 1998;161(1):138–147
20. Chan CW, et al. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol 2003;170(8):4036–4044
21. Liu H, et al. The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol 2008;38(11):3114–3126
22. Shalev I, et al. The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection. Rambam Maimonides Med J 2010;1(1):e0004
23. Gao S, et al. Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther 2010;21(8):969–977
24. Cabrera R, et al. Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25). Dig Dis Sci 2010;55(2):484–495
25. Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21(1):35–43
26. Liu Y, et al. The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway. Biochem Biophys Res Commun 2010;396(2):555–561
27. Foerster K, et al. The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol 2010;53(4):608–615
28. Xu L, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54(1):142–151
29. Alisi A, et al. Human hepatic stellate cells are liver-resident antigen-presenting cells. Hepatology. 2011; 54(3):1107; author reply 1108
30. Mehal WZ. Activation-induced cell death of hepatic stellate cells by the innate immune system. Gastroenterology. 2006;130(2):600–603
31. Uemura T, Gandhi CR. Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent. Br J Pharmacol 2001;133(7):1125–1133
32. Jiang Z, et al. Hepatic stellate cells promote immunotolerance following orthotopic liver transplantation in rats via induction of T cell apoptosis and regulation of Th2/Th3-like cell cytokine production. Exp Ther Med 2013;5(1):165–169
33. Yu MC, et al. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004;40(6):1312–1321
34. Gu X, et al. Interferon- gamma triggers hepatic stellate cell-mediated immune regulation through MEK/ERK signaling pathway. Clin Dev Immunol 2013;2013:389807
35. Chen CH, et al. Cotransplantation of hepatic stellate cells attenuates the severity of graft-versus-host disease. Transplant Proc 2010;42(3):971–975
36. Dangi A, et al. Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J Immunol 2012;188(8):3667–3677
37. Hochst B, et al. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol 2013;59(3):528–535
38. Chou HS, et al. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011;53(3):1007–1019
39. Xu L, et al. Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B. J Huazhong Univ Sci Technol Med Sci 2012;32(4):540–545